A detailed history of Barclays PLC transactions in Applied Therapeutics Inc. stock. As of the latest transaction made, Barclays PLC holds 200,012 shares of APLT stock, worth $1.84 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
200,012
Previous 200,012 -0.0%
Holding current value
$1.84 Million
Previous $1.7 Million -0.0%
% of portfolio
0.0%
Previous 0.0%

Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 15, 2024

BUY
$4.35 - $8.5 $565,943 - $1.11 Million
130,102 Added 186.1%
200,012 $1.7 Million
Q2 2024

Aug 14, 2024

BUY
$4.04 - $6.37 $34,897 - $55,024
8,638 Added 14.1%
69,910 $326,000
Q1 2024

May 15, 2024

BUY
$2.25 - $7.4 $137,862 - $453,412
61,272 New
61,272 $417,000
Q2 2023

Aug 03, 2023

BUY
$0.77 - $1.8 $170 - $397
221 Added 2009.09%
232 $0
Q1 2023

May 04, 2023

BUY
$0.75 - $1.21 $8 - $13
11 New
11 $0
Q2 2022

Aug 12, 2022

SELL
$0.76 - $2.64 $3,030 - $10,525
-3,987 Reduced 99.97%
1 $0
Q1 2022

May 16, 2022

SELL
$1.48 - $6.22 $25,914 - $108,912
-17,510 Reduced 81.45%
3,988 $8,000
Q4 2021

Feb 14, 2022

BUY
$8.77 - $18.29 $31,414 - $65,514
3,582 Added 19.99%
21,498 $193,000
Q3 2021

Nov 09, 2021

BUY
$13.54 - $22.06 $211,034 - $343,827
15,586 Added 668.93%
17,916 $298,000
Q2 2021

Aug 13, 2021

SELL
$14.05 - $25.04 $150,686 - $268,554
-10,725 Reduced 82.15%
2,330 $49,000
Q1 2021

May 13, 2021

BUY
$16.57 - $28.65 $143,463 - $248,051
8,658 Added 196.91%
13,055 $244,000
Q4 2020

Feb 11, 2021

SELL
$15.44 - $24.23 $28,394 - $44,558
-1,839 Reduced 29.49%
4,397 $97,000
Q3 2020

Nov 12, 2020

SELL
$19.43 - $35.36 $192,104 - $349,604
-9,887 Reduced 61.32%
6,236 $129,000
Q2 2020

Aug 12, 2020

SELL
$29.41 - $51.23 $254,396 - $443,139
-8,650 Reduced 34.92%
16,123 $584,000
Q1 2020

May 13, 2020

BUY
$19.54 - $55.47 $64,638 - $183,494
3,308 Added 15.41%
24,773 $810,000
Q4 2019

Feb 10, 2020

BUY
$10.16 - $28.14 $207,975 - $576,025
20,470 Added 2057.29%
21,465 $586,000
Q3 2019

Nov 14, 2019

BUY
$8.08 - $10.99 $8,039 - $10,935
995 New
995 $11,000

Others Institutions Holding APLT

About Applied Therapeutics Inc.


  • Ticker APLT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 48,020,700
  • Market Cap $442M
  • Description
  • Applied Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops novel products to target cardiovascular disease, galactosemia, and diabetic complications. Its lead product candidate is AT-007 that has completed phase 1/2 for the treatment of galactosemia in healthy volunteers and adults, as well as is in pediatric clinical study...
More about APLT
Track This Portfolio

Track Barclays PLC Portfolio

Follow Barclays PLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Barclays PLC, based on Form 13F filings with the SEC.

News

Stay updated on Barclays PLC with notifications on news.